Patents by Inventor Ilia V. Davydov

Ilia V. Davydov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF SCREENING ANTIGEN-BINDING MOLECULES BY NORMALIZING FOR THE CONCENTRATION OF ANTIGEN-BINDING MOLECULE
    Publication number: 20230304190
    Abstract: The invention provides singleplex and multiplex assays for screening of antigen-binding molecules for their affinity to antigens by normalizing for the concentration of the antigen-binding molecule.
    Type: Application
    Filed: May 9, 2023
    Publication date: September 28, 2023
    Inventors: Ka Y. KWONG, Ilia V. DAVYDOV
  • Methods of screening antigen-binding molecules by normalizing for the concentration of antigen-binding molecule
    Patent number: 11686013
    Abstract: The invention provides singleplex and multiplex assays for screening of antigen-binding molecules for their affinity to antigens by normalizing for the concentration of the antigen-binding molecule.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: June 27, 2023
    Assignee: MESO SCALE TECHNOLOGIES, LLC.
    Inventors: Ka Y. Kwong, Ilia V. Davydov
  • METHODS OF SCREENING ANTIGEN-BINDING MOLECULES BY NORMALIZING FOR THE CONCENTRATION OF ANTIGEN-BINDING MOLECULE
    Publication number: 20210087709
    Abstract: The invention provides singleplex and multiplex assays for screening of antigen-binding molecules for their affinity to antigens by normalizing for the concentration of the antigen-binding molecule.
    Type: Application
    Filed: February 22, 2019
    Publication date: March 25, 2021
    Inventors: Ka Y. KWONG, Ilia V. DAVYDOV
  • Modulation of angiogenesis through targeting of cysteine oxygenase activity
    Publication number: 20040023311
    Abstract: The invention provides methods and compositions for modulating angiogenesis in a subject. The methods of modulating angiogenesis in a subject include administering to the subject a modulator of N-terminal cysteine oxygenase activity. The invention also provides a method of identifying such a modulator and a method of in vitro screening for modulators of N-terminal cysteine oxygenase activity. Additionally, the invention provides a method of treating an angiogenesis-related disorder.
    Type: Application
    Filed: March 21, 2003
    Publication date: February 5, 2004
    Inventors: Yong Tae Kwon, Ilia V. Davydov, Rong-gui Hu, Fangyong Du, Alexander Varshavsky